A multiple-dose, randomized, multicenter, phase II clinical trial to evaluate the efficacy, safety, and pharmacokinetic characteristics of SR604 Injection in patients with von Willebrand disease

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: a9e49ea7f2a969d52ddeaa2e6b6a59db91857498
First added on: Sep 12, 2026